Press Releases August 6, 2026 08:47 AM

Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call

Milestone Scientific Announces Q2 2026 Financial Results Conference Call Scheduled for August 14

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
MLSS

Milestone Scientific Inc., a developer of computerized drug delivery instruments, will host a conference call on August 14, 2026, to discuss its financial results for the second quarter ended June 30, 2026. The call will also cover corporate progress and developments. Milestone specializes in technology-driven medical and dental injection devices aimed at improving precision and patient comfort.

Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
MLSS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Milestone Scientific will report Q2 2026 financial results on August 14, 2026.
  • Company develops innovative computer-controlled injection technology using proprietary Dynamic Pressure Sensing Technology®.
  • The financial update and corporate progress could provide insight into the company's performance and developments in medical and dental technology sectors.

ROSELAND, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, August 14, 2026, to discuss the company’s financial results for the second quarter ended June 30, 2026, as well as the company’s corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 252290. A live webcast and replay are available here: https://www.webcaster5.com/Webcast/Page/2306/54387.

An audio replay of the call will be available through August 28, 2026, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and by entering the access code: 54387.

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS) is a technology-focused medical research and development company that patents, designs, and develops innovative injection technologies and instruments for medical and dental applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.

Contact:

HAYDEN IR:
James Carbonara
(646)-755-7412
[email protected]

Brett Maas
(646) 536-7331
[email protected]


Risks

  • Financial results may show volatility or underperformance impacting market perception.
  • Dependence on successful adoption and commercialization of proprietary technology in a competitive medical devices market.
  • Potential regulatory or product development risks affecting pipeline and future revenues.

More from Press Releases

LPL and Private Advisor Group Welcome Paxel Financial Consulting Aug 6, 2026 Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform Aug 6, 2026 Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026 Aug 6, 2026 SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026 Aug 6, 2026 Celcuity Schedules Release of Second Quarter 2026 Financial Results and Webcast/Conference Call Aug 6, 2026